Abstract |
Mupirocin ointment is a widely used topical drug for the treatment of bacterial skin infections. However, ointments have some limitations which motivated the development of a film forming spray of mupirocin. Mupirocin spray (2%) was formulated with Eudragit E100 as a film forming agent and tested for its antibacterial and anti-biofilm activities against Escherichia coli, a skin pathogen causing wound and surgical site infections. Treatment with mupirocin spray resulted in significant antibacterial and anti-biofilm activities (inhibition and disruption) with single spray and sub-actual dose concentrations at par with the commercial ointment concentration. The spray formulation was found to be non-toxic to fibroblast cells and greatly resisted removal from the site of application upon washing, in contrast to the ointment which was significantly removed after a single wash. This is the first study to develop and evaluate a spray formulation for mupirocin that forms a stable thin film for sustained release of the drug.
|
Authors | Dhamodharan Bakkiyaraj, Rutthapol Sritharadol, Alwar Ramanujam Padmavathi, Titpawan Nakpheng, Teerapol Srichana |
Journal | Biofouling
(Biofouling)
Vol. 33
Issue 7
Pg. 591-600
(08 2017)
ISSN: 1029-2454 [Electronic] England |
PMID | 28686044
(Publication Type: Journal Article)
|
Chemical References |
- Acrylates
- Aerosols
- Anti-Bacterial Agents
- Eudragit E100
- Ointments
- Polymers
- Mupirocin
|
Topics |
- Acrylates
(chemistry)
- Administration, Cutaneous
- Aerosols
- Anti-Bacterial Agents
(administration & dosage, pharmacology, toxicity)
- Biofilms
(drug effects)
- Cell Line
- Cell Survival
(drug effects)
- Drug Compounding
- Escherichia coli
(drug effects, isolation & purification)
- Humans
- Mupirocin
(administration & dosage, pharmacology, toxicity)
- Ointments
- Polymers
(chemistry)
- Skin Diseases, Bacterial
(drug therapy)
- Staphylococcal Infections
(drug therapy)
- Wound Infection
(drug therapy)
|